COVID-19 rapid test EZER™

flufor antigensprotein

The EZERTM Flu & COVID-19 Antigen Duo Rapid Test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV-2, influenza A and influenza B directly from nasal swab specimens obtained from individuals, who are suspected of respiratory viral infection, within the first three days of onset of symptoms. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar.These viral antigens are generally detectable in nasal swab samples during the acute phase of infection. This test is for laymen with self-collected nasal (nares) swab samples from individuals aged 14 years or older, or adult collected nasal swab samples from individuals aged 2 years or older. Results are for the simultaneous identification of nucleocapsid antigens of SARS-CoV-2, influenza A and influenza B, but does not differentiate between SARS-CoV and SARS-CoV-2 viruses. Detection EZERTM Flu & COVID-19 Antigen Duo Rapid Test is the simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A and influenza B in nasal swab specimens. Limit Of Detection (LoD) SARS-CoV-2: 140 TCID50/mL Influenza A Influenza Viral Strain - Calculated LOD (TCID 50 /mL) A/New Caledonia/20/1999_H1N1 - 4.25x103 A/California/04/2009_H1N1 - 2.11x103 A/PR/8/34_H1N1 - 7.31x102 A/Bean Goose/Hubei/chenhu XVI35-1/2016_H3N2 - 2.47x102 A/Guizhou/54/89_H3N2 - 1.98x102 A/Human/Hubei/3/2005_H3N2 - 1.46x104 A/Bar-headed Goose/QH/BTY2/2015_H5N1 - 9.88x104 A/Anhui/1/2013_H7N9 - 1.98x105